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Abstract
In cases of difficult biliary cannulation, transpancreatic sphincterotomy (TPS) can be an alternative approach of biliary 
access. However, its success and safety profile have not been studied in detail. A systematic review and meta-analysis were 
performed to study the overall cannulation success and adverse events of TPS. These outcomes were also compared to other 
advanced cannulation methods. A systematic literature search was conducted to find all relevant articles containing data on 
TPS. Successful biliary cannulation and complications rates [post-ERCP pancreatitis (PEP), bleeding, and perforation rates] 
were compared in the pooled analyses of prospective comparative studies. The overall outcomes were calculated involving all 
studies on TPS. TPS was superior compared to needle-knife precut papillotomy (NKPP) and the double-guidewire method 
(DGW) regarding cannulation success (odds ratio [OR] 2.32; 95% confidence interval [CI] 1.37–3.93; and OR 2.72; 95% 
CI 1.30–5.69, respectively). The rate of PEP did not differ between TPS and NKPP or DGW; however, TPS (only retrospec-
tive studies were available for comparison) proved to be worse than needle-knife fistulotomy in this regard (OR 4.62; 95% 
CI 1.36–15.72). Bleeding and perforation rates were similar among these advanced techniques. There were no data about 
long-term consequences of TPS. The biliary cannulation rate of TPS is higher than that of the other advanced cannulation 
techniques, while the safety profile is similar to those. However, no long-term follow-up studies are available on the later 
consequences of TPS; therefore, such studies are strongly needed for its full evaluation.
Keywords Cholangiopancreatography, endoscopic retrograde/adverse effects · Cholangiopancreatography, endoscopic 
retrograde/methods · Postoperative hemorrhage/etiology · Sphincterotomy, endoscopic/adverse effects · Sphincterotomy, 
endoscopic/methods
Introduction
Biliary access during endoscopic retrograde cholan-
giopancreatography (ERCP) is successful after a few 
attempts with basic cannulation methods in around 80% 
of the cases. The European Society of Gastrointestinal 
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Endoscopy (ESGE) recommends guidewire-assisted can-
nulation over contrast material injection during the initial 
attempts because of the higher rate of success and a lower 
rate of post-ERCP pancreatitis (PEP) [1]. However, in chal-
lenging cases, the initial attempts to achieve selective bil-
iary cannulation can fail even in the hands of experienced 
endoscopists. A consensus definition of difficult biliary 
cannulation is still lacking. The current ESGE guideline 
defines it as more than five contacts with the papilla while 
attempting to cannulate, more than 5 min spent attempting 
to cannulate the papilla after visualization, or more than 
one unintended pancreatic duct cannulation or opacifica-
tion. The time limit of the standard cannulation technique 
is extended to 10 min, but other aspects are identical in 
another new international recommendation [2]. Early use 
of advanced cannulation techniques is advised in these situ-
ations to prevent further papillary trauma. Two scenarios 
are possible in case of failed biliary access: Needle-knife 
precut methods or pancreatic guidewire-assisted methods 
can be applied if the guidewire is inserted into the pancre-
atic duct [1].
Pancreatic guidewire-assisted methods can be classi-
fied as single-guidewire methods (cannulation attempts, 
contrast material injection, or precut after leaving the 
guidewire in the pancreatic duct), double-guidewire tech-
nique (DGW) [3], and transpancreatic (biliary) sphincter-
otomy (TPS) [4]. A recent meta-analysis of randomized 
controlled trials showed that the DGW technique has a 
higher PEP rate compared to other advanced methods 
despite its relative “noninvasiveness” [5]. Our previous 
meta-analysis showed that TPS is an effective technique 
which provides a higher rate of successful biliary access; 
furthermore, its application results in lower bleeding and 
PEP rates when compared to needle-knife precut papil-
lotomy (NKPP) [6].
The needle-knife precut techniques are freehand precut 
starting either from the papillary orifice (NKPP) or at the 
papillary roof (needle-knife fistulotomy, NKF). These tech-
niques can also be applied after pancreatic guidewire or 
prophylactic pancreatic stents (PPS) insertion. In fact, some 
studies are showing better outcomes (i.e., higher success 
and lower complication rates) with this method compared 
to the freehand precut [7]. NKPP with a small incision over 
a pancreatic stent improves the success rate and reduces 
the complication rate in difficult biliary cannulations [7] or 
when compared to standard cannulation [8]. Some studies 
suggest that NKF is superior to NKPP in terms of success 
and complications, providing a lower PEP rate by avoiding 
the trauma of the orifice [9].
In the present systematic review, the efficacy and safety 
of the rarely used TPS technique are scrutinized further 
by comparing them with other frequently used advanced 
cannulation methods. TPS was first described by Goff et al. 
[4], and he published results from 51 patients with remark-
able success rate and safety profile of TPS later on [10]. 
Since then, several case series, retrospective and prospec-
tive comparative studies, and few randomized controlled 
trials (RCTs) have been published. On the other hand, con-
cerns have been raised about the long-term safety of this 
technique [11]. The possibility of pancreatic stenosis, as 
seen in the cases of therapeutic pancreatic sphincteroto-
mies, should not be ignored [11, 12]. Here, we summarize 
the available evidence of the success rate, immediate, and 
late adverse events related to TPS in comparison with other 
advanced cannulation methods by executing a systematic 
review.
Methods
Search Strategy
A systematic literature search was conducted to find all rel-
evant articles containing data on TPS in accordance with the 
PRISMA guideline [13]. The search strategy included the 
following terms: “transpancreatic septotomy” or “transpan-
creatic sphincterotomy” or “transpancreatic septostomy” 
or “transpancreatic precut sphincterotomy” or “pancreatic 
sphincterotomy” or “transpancreatic papillary septotomy” 
or “transpancreatic sphincter precut” or “transpancreatic 
duct precut” or “pancreatic sphincter precutting” or “pan-
creatic precut sphincterotomy” or “transpancreatic precut 
septotomy” or “transpancreatic precut septostomy” or “pan-
creatic septotomy” or “pancreatic septostomy” or “pancre-
atic precut” or “transpancreatic precut” or “transpancreatic.” 
EMBASE, PubMed, Scopus, Web of Science, ProQuest, and 
Cochrane Library databases were searched from their incep-
tion till February 8, 2018.
Inclusion Criteria
In order to compare TPS to DGW and NKPP, only prospec-
tive studies were included. However, only retrospective data 
were available in the comparison of TPS–NKF, and these 
were also included in our analysis. Appropriate conference 
abstracts were also analyzed to minimize publication bias, 
and additional subgroup analyses excluding them were car-
ried out to show their effects on outcomes.
Comparative and also non-comparative prospective 
and retrospective studies were included in the calculation 
of overall success and complications rate of TPS. Rand-
omized controlled trials (RCT) and prospective and retro-
spective observational studies were analyzed separately 
(Table 4).
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Study Selection and Data Collection
Titles and abstracts of studies identified were screened by 
two authors (D.P. and Á.V.) independently, and then, the 
full-text articles were searched to identify eligible studies. 
Data extraction and risk of bias assessment were done inde-
pendently by the authors. Peer-reviewed works and confer-
ence abstracts were included. Unpublished data were not 
requested from the authors. Any disagreement was resolved 
by discussion in plenum. Prophylactic measures to prevent 
PEP; furthermore, the length and results of follow-up were 
also collected and analyzed.
Risk of Bias Assessment
The Newcastle–Ottawa scale (NOS) was used for prospec-
tive and retrospective studies to assess risk of bias within 
the individual studies [14] (Table 5). Randomized controlled 
trials were assessed by the Cochrane Risk of Bias Tool [15] 
(Table 6).
Statistical Methods
Pooled odds ratios (ORs) and their 95% confidence 
intervals (CIs) were calculated to compare the biliary 
cannulation success and PEP rates among the different 
cannulation techniques. Risk difference (RD) was cal-
culated to compare the bleeding and perforation rates in 
order to avoid overestimation since OR or RR calcula-
tions would exclude those studies where zero events were 
reported. The random-effect model of DerSimonian and 
Laird [16] was used in meta-analysis. Subgroup analy-
ses excluding studies with sequential designs and that 
reported only in an abstract format were also carried out. 
Sensitivity analyses were carried out using four types 
of summary statistics (RR [risk ratio] vs. OR vs. RD 
vs. Peto’s OR) and two types of meta-analytical models 
(fixed vs. random effects) to test the robustness of our 
findings [17]. Heterogeneity was tested with two meth-
ods, namely the Cochrane’s Q and the I2 statistics. The 
Q test was computed by summing the squared deviations 
of each study’s estimate from the overall meta-analysis 
estimate; P values were obtained by comparing the sta-
tistical results with a χ2 distribution with k − 1 degrees 
of freedom (where k was the number of studies). A P 
value of less than 0.1 was considered suggestive of sig-
nificant heterogeneity. The I2 statistic represents the 
percentage of the total variability across studies that is 
due to heterogeneity, i.e., I2 value between 0 and 40% 
indicates low, 30–60% moderate, 50–90% substantial, 
and 75–100% considerable heterogeneity, based on 
Cochrane Handbook for Systematic Reviews of Inter-
ventions [17]. Publication bias was planned to be exam-
ined by visual inspection of funnel plots and the Egger’s 
method [18]. Meta-analytical calculations were done 
with Review Manager (RevMan) computer program (ver-
sion 5.3, Copenhagen: The Nordic Cochrane Centre, The 
Cochrane Collaboration, 2014).
Results
Study Selection
Altogether, 2787 records were identified during database 
search: 510 in EMBASE, 339 in PubMed, 968 in Sco-
pus, 255 in Web of Science, 544 in ProQuest, and 171 in 
Cochrane Library, respectively. The latest search was run 
on February 8, 2018, and finally, 33 relevant studies were 
included in the qualitative synthesis, while data from 14 
studies were extracted for the meta-analysis (Fig. 1).
Characteristics of Studies Included
Characteristics of the included studies with the applied PEP 
prophylaxis (Table 1), the definitions of difficult biliary 
access and the endoscopists/centers experience (Table 2), 
and the late adverse events are summarized in Table 3.
Three RCTs [19–21] and two prospective observational 
studies [22, 23] compared TPS and DGW. One of them was 
only available in abstract form [19]. Two of them used a 
sequential design [22, 23], applying TPS only after DGW, 
as a rescue technique.
Two RCTs [24, 25] and three prospective observational 
studies [22, 23, 26] provided data on the comparison of TPS 
vs. NKPP, two of them with sequential design [22, 23]. New 
prospective studies were not identified after our previous 
meta-analysis; however, we conducted further sensitivity 
and subgroup analyses in this comparison [6].
Comparison of TPS and NKF was not found in any pro-
spective studies; four retrospective studies (two of them only 
in abstract form) were identified and analyzed to synthesize 
available comparative evidence [9, 27–29].
Two prospective case series of TPS without relevant 
comparisons to other advanced cannulation methods [30, 
31] and, additionally, 23 retrospective observational stud-
ies with reported outcome data were included in the pooled 
analyses of overall outcomes of TPS [4, 9, 10, 27–29, 32–48] 
(Table 4).
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Methodological Quality and Risk of Bias Assessment
The risk of bias in the prospective (not RCTs) and the four 
retrospective studies included in the meta-analyses was 
analyzed with the NOS (Table 5). In most of the full-text 
studies, baseline characteristics of cohorts were reported 
with comparable, homogeneous groups. Technical details 
of interventions were thoroughly reported; all full-text stud-
ies defined precut methods appropriately. On the other hand, 
definitions of adverse outcomes somewhat varied; however, 
most studies used the consensus definitions [49]. The appro-
priate length of follow-up is questionable in the cases of 
late adverse events, and only one prospective study reported 
the length of follow-up as longer than 30 days [30]. The 
abstracts contained limited information about the above-
mentioned details; therefore, they carry an unclear risk of 
bias.
Fig. 1  Flow diagram of litera-
ture search 2787 records identified through database searching:
EMBASE 510, PubMed 339, Scopus 
968, Web of Science 255, ProQuest 
544, Cochrane Library 171
1774 records screened after 
duplicates removed
109 articles assessed for eligibility 
1665 articles excluded (title and/or 
abstract not relevant)
76 articles excluded, with reasons:
- review or meta-analysis: 18
- inappropriate intervention: 44
- letter to the editor: 3
- editorial: 6
- guidelines: 2
- intervention group not reported 
separately: 3
33 studies included for qualitative 
synthesis
14 studies included in quantitative 
synthesis (meta-analysis)
19 articles excluded, with reasons:
- retrospective studies in 
comparisons where prospective data 
were available: 19
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In case of RCTs, the Cochrane Risk of Bias Tool was 
used (Table 6). Only one study [21] reported the method 
of randomization and the method of ensuring allocation 
concealment. Blinding in studies of endoscopic interven-
tions at participant and personnel level is difficult to execute 
and therefore could not be expected. However, blinded late 
outcome assessment (PEP, late bleeding, perforation) could 
be arranged more easily. Nevertheless, none of the studies 
reported blinding of any kind. Three out of five RCTs did 
not report the rate of cholangitis; therefore, this outcome 
could not be analyzed [19, 24, 25]. One RCT was only 
published in abstract form which makes the data quality 
questionable; consequently, this study carries a high risk 
of bias [19].
Publication bias could not be reliably assessed based on 
funnel plots or by the Egger’s method because of the small 
number of included studies. According to the Cochrane 
Handbook, funnel plots and other statistical tests are not 
advised to assess small study effect and publication bias 
under ten studies per analysis [17, 18, 50].
Endoscopists’ Experience and Centers’ Case Volumes 
in the Prospective Studies
Most of the prospective studies reported endoscopists’ 
experience in yearly case numbers, some in lifetime 
ERCP numbers, too. Based on the reported numbers, 
all endoscopists performed more than 200 ERCPs/year. 
In one study, the caseload of the endoscopists exceeded 
500 ERCPs annually [30]. Trainee participation was 
not reported in any of the studies. Most of the centers 
reported high-volume ERCPs (even above 1000 proce-
dures/year [23, 24]), only one study [9] reported lower 
numbers (< 300 ERCPs/year), while no information was 
found about center or endoscopist caseload in one study 
[29] (Table 2).
Biliary Cannulation Success Rate
TPS showed superiority in success rate compared to 
DGW (OR 2.72; 95% CI 1.30–5.69; 176 and 235 patients, 
Table 1  Characteristics of the studies included in the meta-analysis with the prophylactic measures to prevent post-ERCP pancreatitis (PEP)
PPS prophylactic pancreatic stent, RCT randomized controlled trial, DGW double-guidewire cannulation, TPS transpancreatic biliary sphincter-
otomy, NKPP needle-knife precut papillotomy, NKF needle-knife fistulotomy, NR not reported
Study Study design Comparison Sequen-
tial 
design
Form of publication PPS use Pharmacologic pre-
vention
Cha et al. [19] RCT DGW versus TPS No Abstract NR NR
Sugiyama et al. [20] RCT DGW versus TPS No Full text In all cases Nafamostat
Yoo et al. [21] RCT DGW versus TPS No Full text No No
Kim et al. [22] Prospective DGW versus TPS 
versus NKPP
Yes Full text 2/27 (7%) in DGW 
group, 25/38 (66%) 
in TPS group, 
P < 0.001
No
Zou et al. [23] Prospective DGW versus TPS 
versus NKPP
Yes Full text 14/63 (22%) in all 
patients compared, 
not reported sepa-
rately in DGW/TPS 
groups
No
Catalano et al. [24] RCT NKPP versus TPS No Full text PPS in some patients No
Zang et al. [25] RCT NKPP versus TPS No Full text No No
Espinel-Diez [26] Prospective NKPP versus TPS No Full text No No
Horiuchi et al. [9] Retrospective NKF versus TPS No Full text No No
Katsinelos et al. [27] Retrospective NKPP versus NKF 
versus TPS
No Full text PPS in some patients Diclofenac and 
somatostatin in some 
patients
Lee et al. [28] Retrospective NKF versus TPS No Abstract No Protease inhibitor
Wen et al. [29] Retrospective NKF versus TPS No Abstract NR NR
Kahaleh et al. [30] Prospective No No Full text 29/116 (25%) of all 
cases
NR
Weber et al. [31] Prospective No No Full text No NR
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respectively; I2 = 50%) (Fig. 2a) and NKPP (OR 2.32; 95% 
CI 1.37–3.93; 292 and 260 patients, respectively; I2 = 7%) 
(Fig. 2b). The success rate of TPS and NKF did not differ 
(OR 1.38; 95% CI 0.32–5.96; 295 and 141 patients, respec-
tively; I2 = 22%) (Fig. 2c).
In the TPS versus DGW comparison of cannulation suc-
cess rates, no significant difference was detected between the 
two methods if only RCTs were included (OR 3.02; 95% CI 
0.73–12.59; 113 and 107 patients, respectively; I2 = 69%), 
probably because of the greater confidence intervals of the 
results. On the other hand, subgroup analysis of full-text 
studies found the superiority of TPS over DGW with regard 
to cannulation success rate (Suppl. Figure 1).
The overall success rate of TPS in prospective studies was 
89.7% (564/629). The success rate was the same if all studies 
were analyzed (89.6%, 2343/2615), as well as the separate 
analysis of RCTs resulted in similarly high value (91.7%, 
199/217) (Table 4).
Post‑ERCP Pancreatitis
No significant difference was found between the TPS versus 
DGW (OR 0.72; 95% CI 0.24–2.10; 151 and 134 patients, 
respectively; I2 = 55%) (Fig. 3a) and TPS versus NKPP (OR 
1.63; 95% CI 0.48–5.47; 265 and 242 patients, respectively; 
I2 = 57%) (Fig. 3b) comparisons. However, the TPS tech-
nique showed a higher PEP rate compared to NKF method 
(OR 4.62; 95% CI 1.36–15.72; 295 and 141 patients, respec-
tively; I2 = 16%) (Fig. 3c).
If we excluded abstracts from the NKF versus TPS com-
parison, the significant difference disappeared (OR 3.49; 
95% CI 0.20–62.21; 86 and 115 patients, respectively; 
I2 = 63%) and expectedly, a wide confidence interval could 
be seen (Suppl. Figure 2). In the other subgroups, no differ-
ences were found when sequential studies or abstracts were 
omitted from the analyses. Inclusion of RCTs only did not 
result any change in significance regarding TPS versus DGW 
and TPS versus NKPP comparisons.
The overall PEP rate of TPS was 8.1% (49/604) in pro-
spective studies, 7.1% (183/2590) in all studies, and 7.4% 
(16/217) in RCTs (Table 4).
Prophylactic Pancreatic Stent and Nonsteroid 
Anti‑inflammatory Suppository Use
Only one recently published study used PPS in all patients 
undergoing TPS [20], while all the others reported no or 
only some PPS implantation in the TPS cases (Table 1). 
Pharmacologic prevention of PEP was applied in three stud-
ies [20, 27, 28]; however, the recommended nonsteroid anti-
inflammatory drug (NSAID) suppositories were not used 
or not reported in any of the studies included in the meta-
analyses (Table 1).
Bleeding
The pooled analysis did not show any difference in bleed-
ing rate when TPS was compared to DGW (risk difference 
[RD] 0.01; 95% CI − 0.03 to 0.05; 109 and 95 patients, 
respectively; I2 = 0%) (Fig. 4a), NKPP (RD − 0.00; 95% CI 
− 0.04 to 0.03; 268 and 239 patients, respectively; I2 = 20%) 
(Fig. 4b), and NKF (RD 0.00; 95% CI − 0.03 to 0.03; 295 
and 141 patients, respectively; I2 = 0%) (Fig. 4c).
Subgroup analyses did not alter the findings of bleeding 
rates significantly.
The overall bleeding rate of TPS was 3.4% (19/562) in 
prospective studies, 2.0% (50/2548) in all studies, and 1.7% 
(3/175) in RCTs (Table 4).
Perforation
Perforation rates did not differ when comparing TPS ver-
sus DGW (RD − 0.01; 95% CI − 0.04 to 0.03; 109 vs. 95; 
I2 = 0%) (Fig. 5a), TPS versus NKPP (RD − 0.00; 95% CI 
− 0.02 to 0.01; 267 and 240 patients, respectively; I2 = 0%) 
Table 3  Late adverse events in the prospective studies, where longer-term follow-ups were reported
Studies without follow-up data are not shown
RCT randomized controlled trial, PD pancreatic duct, NR not reported
Study Study design Length of follow-up Type Complications PD stricture
Kim et al. [22] Prospective, observational NR NR No No chronic pancreatitis 
or ductitis from PD 
stenting
Catalano et al. [24] RCT NR Telephone contact and office 
visits
No No
Kahaleh et al. [30] Prospective, observational Median follow-up 
was 5 months 
(2–35)
Clinic visit and/or telephone 
interview by a nurse
No No
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(Fig. 5b), and TPS versus NKF (RD 0.00; 95% CI − 0.02 to 
0.03; 295 and 141 patients, respectively; I2 = 0%) (Fig. 5c).
Subgroup analyses did not alter the findings in perfora-
tions rates significantly.
The overall perforation rate was 0.5% (3/562) in prospec-
tive studies, 0.4% (11/2548) in all studies, while 0% (0/175) 
in RCTs (Table 4).
Sensitivity and Subgroup Analyses
Application of other meta-analytical models (fixed-effect vs. 
random-effect analysis) and summary statistics (OR vs. RR 
vs. RD vs. Peto’s OR) did not affect the outcomes signifi-
cantly in the main analyses; thus, our conclusions remain 
unaltered (Suppl. Table 1).
However, subgroup analyses excluding non-RCTs, 
sequential trials, and studies only available in an abstract 
form altered significantly some results (i.e., success rate in 
TPS vs. DGW and PEP rate in TPS vs. NKF comparisons, 
respectively) (Suppl. Table 2, Figs. 1 and 2).
Follow‑Up
Pancreatic duct stricture or chronic pancreatitis could poten-
tially develop after pancreatic sphincterotomy; therefore, a 
longer follow-up period is needed to detect these adverse 
outcomes [11]. Small caliber pancreatic stents could rarely 
cause pancreatic ductal changes in long term (1 month or 
longer) [51, 52]. Only one prospective study, a case series 
with 116 patients, reported a median 5-month follow-up 
Table 5  Risk of bias assessment of prospective, non-randomized, and retrospective studies with the Newcastle–Ottawa scale
Selection Comparison Exposure
S/1 S/2 C/1 C/2 E/1 E/2 E/3
Espinel Diez, 2013
Horiuchi, 2007
Kahaleh, 2004*
Katsinelos, 2012
Kim, 2015
Lee (abstract), 
2015
Weber, 2008*
Wen (abstract), 
2017
Zou, 2015
S/1: Representativeness of the exposed cohort (transpancreatic sphincterotomy group compared to advanced cannulation technique group); S/2: 
Selection of the non-exposed cohort (advanced cannulation technique group); C/1: Comparability of cohorts on the basis of similar indications 
of procedure; C/2: Comparability of cohorts on the basis of age; E/1: Assessment of outcome (were blinded assessment executed?); E/2: Was 
follow-up long enough? (longer than 14 days); E/3: Adequacy of follow-up of cohorts (is any attrition of patients present?) Two studies are not 
comparing TPS to another advanced cannulation technique and are marked with an asterisk
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(range 2–35) with no late adverse events [30]. Another 
paper similarly did not report late chronic pancreatitis or 
ductitis from PPS; no strictures were described during 
longer, however not specified, follow-up [22] (Table 3). A 
few retrospective studies also published longer-term results: 
Miao et al. [45] reported no stricture after 4 months of 
follow-up period, while Barakat et al. [33] found no late 
stricture formation after an unknown length of “long-term” 
follow-up.
Discussion
This systematic review and meta-analysis show that TPS 
could be equally successful or even slightly better in the set-
ting of difficult biliary access compared to other advanced 
cannulation methods. Analyzing only the prospective studies 
with regard to cannulation success rates TPS seems superior 
to DGW and NKPP, while TPS and NKF are equally effec-
tive. DGW and NKPP carry a similar risk of PEP compared 
to TPS; however, PEP occurs more frequently with TPS than 
with NKF. No difference in bleeding and perforation rates 
was found when comparing TPS to the other advanced can-
nulation methods.
Prospective observational studies and RCTs were ana-
lyzed whenever it was possible to gain the best evidence. 
Between-study heterogeneity was low or moderate in 
most analyses, making our conclusions more accurate. 
Sensitivity analyses and application of different statisti-
cal and meta-analytical methods did not reveal any sig-
nificant changes in the main associations. However, sub-
group analyses excluding sequential studies revealed that 
the significant difference disappeared in some analyses, 
thereby weakening our conclusion in the findings of suc-
cess rate of TPS versus DGW and PEP rate in TPS versus 
NKF. However, this is most probably the result of the low 
case numbers, leading to imprecision and wider confidence 
intervals.
Exceptionally low cannulation rates (as low as 72%) 
and high PEP rates (36.8%) were seen in the sequential 
studies (Table 4) that probably could be explained by the 
previous DGW attempts causing papillary trauma and con-
sequential edema. Our experience also shows that TPS 
after papillary trauma induced by precut results low rate 
of biliary access, while it is highly successful if applied 
primarily [53]. Based on these considerations, we recom-
mend the TPS technique in the early phase of difficult 
biliary access when pancreatic guidewire insertion reached 
unintentionally.
The overall cannulation success rate of TPS is close to 
90% in all studies and also in subgroups by different study 
designs, which makes this pancreatic guidewire-assisted 
method a good alternative to DGW and other advanced can-
nulation methods. The overall biliary cannulation success 
Table 6  Risk of bias assessment 
of RCTs with the Cochrane 
Collaboration risk of bias tool
RCTs
1 2 3 4 5 6 7
Cha (abstract), 
2012
Catalano, 2004
Sugiyama, 2017
Yoo, 2013
Zang, 2014
1: Random sequence generation; 2: allocation concealment; 3: blinding of participants and person-
nel; 4: blinding of outcome assessment; 5: incomplete outcome data; 6: selective reporting; 7: other 
bias
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rate of DGW was only 61% in the studies where it was 
compared to TPS (Fig. 2a). Furthermore, a meta-analysis 
of seven RCTs with DGW showed that successful biliary 
cannulation was achieved only in 82% of cases [5]. NKPP 
is also a frequently used method in cases of difficult biliary 
access. The average cannulation success rate of NKPP was 
approximately 80% (647/812) in all NKPP studies and 77% 
(201/260) in prospective studies according to our previous 
meta-analysis [6].
PEP rate of TPS is similar to other advanced cannula-
tion methods (7.1%; 183/2590; 0–30%, Table 4). NKPP 
seems comparable to TPS with its 8.8% (70/794) over-
all PEP rate measured in our previous meta-analysis [6]. 
NKF, however, could be better to avoid PEP (Fig. 3c). 
With the uniform use of PPS and NSAID suppositories 
in all TPS cases, a PEP rate might be even lower [20, 48] 
as the significant protective effect of PPS has been well 
proven. Importantly, its insertion should not be problem-
atic since the guidewire is already in the pancreatic duct 
while performing TPS.
Bleeding rate of TPS is in the range of 2–4%, which is 
comparable to the widely accepted and frequently used nee-
dle-knife precut techniques (4%; 30/745 of NKPP cases) [6]. 
The rate of perforation was around 0.5% which is remark-
ably low for a precut technique, and no difference was found 
in this respect between TPS and the other advanced cannula-
tion techniques.
There are several limitations of our analyses. First of 
all, the low number of prospective studies with only small 
cohorts of patients weakens the conclusions. Sequential 
Fig. 2  a Forest plot of cannulation success rate of transpancreatic 
sphincterotomy (TPS) versus double-guidewire technique (DGW) in 
prospective studies; b comparison of cannulation success rate of TPS 
versus needle-knife precut papillotomy (NKPP) in prospective stud-
ies; c comparison of cannulation success rate of TPS versus needle-
knife fistulotomy (NKF) in available comparative retrospective stud-
ies
 Digestive Diseases and Sciences
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studies were also included which could alter our results. 
However, in the comparison of DGW or NKPP vs. TPS, 
sequential designs could affect the TPS cannulation suc-
cess and adverse event rate only to the worse due to the 
prolonged cannulation attempt and greater trauma of the 
papilla. The lack of information on the use of effective pre-
ventive methods (PPS, NSAID suppositories) undermines 
the assessment of PEP rates. New studies are lacking in 
this field with the consistent use of PPS and NSAID sup-
positories. It should be noted, however, that the PEP rate 
was only 1.1% in the study of Sugiyama et al. [20], where 
all patients received PPS after TPS, compared to the rate of 
7.1% pooled from all studies where most patients did not 
have PPS. Besides that, the definitions of outcomes were 
not standardized in all cases. Nonetheless, most prospec-
tive studies used the consensus definitions [49]. Publication 
bias cannot be ruled out due to the low number of studies 
per analysis.
The possible benefit of TPS over the freehand precut 
techniques is that it is a wire-assisted method, with better 
control of the cut. For that reason, it could be appealing 
in those situations, where the papillary tract is smaller, or 
the position of the scope is unstable. Furthermore, the PPS 
insertion could also be easily achieved after the precut, since 
the guidewire is already inserted into the pancreatic duct. An 
additional benefit is that the sphincterotome does not need 
Fig. 3  a Forest plot of post-ERCP pancreatitis (PEP) rate of transpan-
creatic sphincterotomy (TPS) versus double-guidewire technique 
(DGW) in prospective studies; b comparison of PEP rate of TPS 
versus needle-knife precut papillotomy (NKPP) in prospective stud-
ies; c comparison of PEP rate of TPS versus needle-knife fistulotomy 
(NKF) in available comparative retrospective studies
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to be changed for the precut. In the unfortunate cases, when 
TPS fails, additional needle-knife incision could be help-
ful to reach deep biliary cannulations and might be used as 
salvage technique in appropriate situations.
The late adverse events of TPS, e.g., pancreatic duct 
stricture and chronic pancreatitis [11], could not be assessed 
properly because only one prospective study reported 
a longer-term (more than 30-day) follow-up with no late 
adverse events [30]. We think that follow-up studies should 
be extended up to 1 year or longer to detect late adverse 
events, e.g., pancreatic duct stricture formation or the devel-
opment of chronic pancreatitis.
These findings show the short-term safety and efficacy of 
TPS and also highlight the necessity of long-term follow-up 
studies after precut papillotomy.
Fig. 4  a Forest plot of bleeding rate after transpancreatic sphincterot-
omy (TPS) versus double-guidewire technique (DGW) in prospective 
studies; b comparison of bleeding rate after TPS versus needle-knife 
precut papillotomy (NKPP) in prospective studies; c comparison of 
bleeding rate after TPS versus needle-knife fistulotomy (NKF) in 
available comparative retrospective studies
 Digestive Diseases and Sciences
1 3
Acknowledgments Open access funding provided by University of 
Pécs (PTE).
Funding Funding was provided from Economic Development and 
Innovation Operative Programme Grant of the National Research, 
Development and Innovation Office (GINOP-2.3.2-15-2016-00048), 
and from the ÚNKP-17-3-I New National Excellence Program of the 
Ministry of Human Capacities.
Compliance with ethical standards 
Competing interests The authors declare that they have no competing 
interests.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution-NonCommercial 4.0 International License 
(http://creat iveco mmons .org/licen ses/by-nc/4.0/), which permits any 
noncommercial use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons license, and indicate 
if changes were made.
References
 1. Testoni PA, Mariani A, Aabakken L, et al. Papillary cannulation 
and sphincterotomy techniques at ERCP: European Society of 
Gastrointestinal Endoscopy (ESGE) clinical guideline. Endos-
copy. 2016;48:657–683.
 2. Liao WC, Angsuwatcharakon P, Isayama H, et al. International 
consensus recommendations for difficult biliary access. Gastro-
intest Endosc. 2017;85:295–304.
 3. Gyokeres T, Duhl J, Varsanyi M, Schwab R, Burai M, Pap A. 
Double guide wire placement for endoscopic pancreaticobiliary 
procedures. Endoscopy. 2003;35:95–96.
 4. Goff JS. Common bile duct pre-cut sphincterotomy: transpancre-
atic sphincter approach. Gastrointest Endosc. 1995;41:502–505.
 5. Tse F, Yuan Y, Moayyedi P, Leontiadis GI, Barkun AN. Dou-
ble-guidewire technique in difficult biliary cannulation for the 
prevention of post-ERCP pancreatitis: a systematic review and 
meta-analysis. Endoscopy. 2017;49:15–26.
 6. Pécsi D, Farkas N, Hegyi P, et  al. Transpancreatic sphinc-
terotomy has a higher cannulation success rate than needle-
knife precut papillotomy—a meta-analysis. Endoscopy. 
2017;49:874–887.
Fig. 5  a Forest plot of comparison of perforation rate after transpan-
creatic sphincterotomy (TPS) versus double-guidewire technique 
(DGW) in prospective studies; b comparison of perforation rate after 
TPS versus needle-knife precut papillotomy (NKPP) in prospective 
studies; c comparison of perforation rate after TPS versus needle-
knife fistulotomy (NKF) in available comparative retrospective stud-
ies
Digestive Diseases and Sciences 
1 3
 7. Kubota K, Sato T, Kato S, et al. Needle-knife precut papillotomy 
with a small incision over a pancreatic stent improves the success 
rate and reduces the complication rate in difficult biliary cannula-
tions. J Hepatobiliary Pancreat Sci. 2013;20:382–388.
 8. Madacsy L, Kurucsai G, Fejes R, Szekely A, Szekely I. Prophy-
lactic pancreas stenting followed by needle-knife fistulotomy in 
patients with sphincter of Oddi dysfunction and difficult cannula-
tion: new method to prevent post-ERCP pancreatitis. Dig Endosc. 
2009;21:8–13.
 9. Horiuchi A, Nakayama Y, Kajiyama M, Tanaka N. Effect of precut 
sphincterotomy on biliary cannulation based on the characteris-
tics of the major duodenal papilla. Clin Gastroenterol Hepatol. 
2007;5:1113–1118.
 10. Goff JS. Long-term experience with the transpancreatic sphincter 
pre-cut approach to biliary sphincterotomy. Gastrointest Endosc. 
1999;50:642–645.
 11. Kozarek R. Flail, flay, or fail: needle-knife versus transpancreatic 
sphincterotomy to access the difficult-to-cannulate bile duct dur-
ing ERCP. Endoscopy. 2017;49:842–843.
 12. Kozarek RA, Ball TJ, Patterson DJ, Brandabur JJ, Traverso LW, 
Raltz S. Endoscopic pancreatic duct sphincterotomy: indica-
tions, technique, and analysis of results. Gastrointest Endosc. 
1994;40:592–598.
 13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred report-
ing items for systematic reviews and meta-analyses: the PRISMA 
statement. Ann Intern Med. 2009;151:264–269.
 14. Wells GA SB, O’Connell D, Peterson J, Welch V, et al. The New-
castle-Ottawa Scale (NOS) for assessing the quality of nonran-
domized studies in meta-analysis. 2011; Available: http://www.
ohri.ca/progr ams/clini cal_epide miolo gy/oxfor d.asp.
 15. Higgins JP, Altman DG, Gøtzsche PC, et al. The cochrane col-
laboration’s tool for assessing risk of bias in randomised trials. 
Bmj. 2011;343:d5928.
 16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control 
Clin Trials. 1986;7:177–188.
 17. Higgins JP, Green S. Cochrane handbook for systematic reviews 
of interventions, vol. 4. New York: Wiley; 2011.
 18. Egger M, Davey Smith G, Schneider M, Minder C. Bias 
in meta-analysis detected by a simple, graphical test. Bmj. 
1997;315:629–634.
 19. Cha S-W, Kim SH, Kim A, et al. 447 DGT versus TPS in patients 
with initial PD cannulation by chance; prospective randomized 
multi-center study. Gastrointest Endosc. 2012;75:AB141.
 20. Sugiyama H, Tsuyuguchi T, Sakai Y, et al. Transpancreatic precut 
papillotomy versus double-guidewire technique in difficult bil-
iary cannulation: prospective randomized study. Endoscopy. 
2018;50:33–39.
 21. Yoo YW, Cha SW, Lee WC, Kim SH, Kim A, Cho YD. Dou-
ble guidewire technique versus transpancreatic precut sphinc-
terotomy in difficult biliary cannulation. World J Gastroenterol. 
2013;19:108–114.
 22. Kim CW, Chang JH, Kim TH, Han SW. Sequential double-guide-
wire technique and transpancreatic precut sphincterotomy for dif-
ficult biliary cannulation. Saudi J Gastroenterol. 2015;21:18–24.
 23. Zou XP, Leung JW, Li YH, et al. Comparison of sequential 
pancreatic duct guidewire placement technique and needle knife 
precut sphincterotomy for difficult biliary cannulation. J Dig 
Dis. 2015;16:741–746.
 24. Catalano MF, Linder JD, Geenen JE. Endoscopic transpancre-
atic for inaccessible obstructed papillary septotomy bile ducts: 
comparison with standard pre-cut papillotomy. Gastrointest 
Endosc. 2004;60:557–561.
 25. Zang J, Zhang C, Gao J. Guidewire-assisted transpancreatic 
sphincterotomy for difficult biliary cannulation: a prospective 
randomized controlled trial. Surg Laparosc Endosc Percutane-
ous Tech. 2014;24:429–433.
 26. Espinel-Diez J, Pinedo-Ramos E, Vaquero-Ayala L, Alvarez-
Cuenllas B, Ojeda-Marrero V. Combined precut in difficult bil-
iary cannulation. Rev Esp Enferm Dig. 2013;105:334–337.
 27. Katsinelos P, Gkagkalis S, Chatzimavroudis G, et al. Compari-
son of three types of precut technique to achieve common bile 
duct cannulation: a retrospective analysis of 274 cases. Dig 
Dis Sci. 2012;57:3286–3292. https ://doi.org/10.1007/s1062 
0-012-2271-8.
 28. Lee YJ, Park YK, Lee MJ, Lee KT, Lee KH, Lee JK. Differ-
ent strategies for transpancreatic septotomy and needle knife 
infundibulotomy due to the presence of unintended pancre-
atic cannulation in difficult biliary cannulation. Gut Liver. 
2015;9:534–539.
 29. Wen J, Li T, Gong B. Efficacy and safety of transpancreatic sep-
totomy, needle-knife fistulotomy or both selected based on unin-
tentional pancreatic access and papillary morphology. J Dig Dis. 
2017;18:41.
 30. Kahaleh M, Tokar J, Mullick T, Bickston SJ, Yeaton P. Pro-
spective evaluation of pancreatic sphincterotomy as a precut 
technique for biliary cannulation. Clin Gastroenterol Hepatol. 
2004;2:971–977.
 31. Weber A, Roesch T, Pointner S, et al. Transpancreatic precut 
sphincterotomy for cannulation of inaccessible common bile duct: 
a safe and successful technique. Pancreas. 2008;36:187–191.
 32. Akashi R, Kiyozumi T, Jinnouchi K, Yoshida M, Adachi Y, 
Sagara K. Pancreatic sphincter precutting to gain selective access 
to the common bile duct: a series of 172 patients. Endoscopy. 
2004;36:405–410.
 33. Barakat MT, Girotra M, Huang RJ, et al. Goff trans-pancreatic 
septotomy is an effective and safe salvage technique following 
failed standard biliary cannulation at ERCP. Gastrointest Endosc. 
2017;85:AB606.
 34. Chan CH, Brennan FN, Zimmerman MJ, Ormonde DG, Raftopou-
los SC, Yusoff IF. Wire assisted transpancreatic septotomy, needle 
knife precut or both for difficult biliary access. J Gastroenterol 
Hepatol. 2012;27:1293–1297.
 35. de-la-Morena-Madrigal EJ. Impact of combined precut tech-
niques on selective biliary cannulation. Rev Esp Enferm Dig. 
2013;105:338–344.
 36. de-la-Morena-Madrigal EJ, Rodriguez Garcia MF, Galera Rode-
nas AB, Perez Arellano E. Biliary cannulation effectiveness 
and pancreatitis risk using two early precut techniques. Rev Esp 
Enferm Dig. 2018;110:74–81.
 37. Esmaily S, Elzubier M, Dwarakanath D, et al. Transpancreatic 
sphincterotomy: a valuable technique for gaining CBD access. 
United Eur Gastroenterol J. 2017;5:A697.
 38. Halttunen J, Keranen I, Udd M, Kylanpaa L. Pancreatic sphincter-
otomy versus needle knife precut in difficult biliary cannulation. 
Surg Endosc. 2009;23:745–749.
 39. Huang C, Kung J, Liu Y, et al. Use of double wire-guided tech-
nique and transpancreatic papillary septotomy in difficult ERCP: 
4-year experience. Endosc Int Open. 2016;4:E1107–E1110.
 40. Javia SB, Priyanka P, Avila N, et al. Transpancreatic sphincter-
otomy (Goff septotomy) is safe and effective in patients with failed 
wire/contrast guided biliary cannulation. Gastrointest Endosc. 
2016;83:AB606.
 41. Kapetanos D, Kokozidis G, Christodoulou D, et al. Case series 
of transpancreatic septotomy as precutting technique for difficult 
bile duct cannulation. Endoscopy. 2007;39:802–806.
 42. Liao C, Park W, Chen A, Friedland S, Banerjee S. Goff trans-pancre-
atic septotomy is an effective and safe biliary cannulation technique 
for patients who fail standard biliary cannulation. Am J Gastroen-
terol. 2011;106:S56–S56.
 43. Lin LF. Transpancreatic precut sphincterotomy for biliary access: the 
relation of sphincterotomy size to immediate success rate of biliary 
cannulation. Diagn Ther Endosc. 2014;2014:864082.
 Digestive Diseases and Sciences
1 3
 44. McGonigle J, Mitra V, Dwarakanath D, Chaudhury B, Majumdar 
D, Hancock J. The safety and efficacy of transpancreatic sphincter-
otomy for difficult CBD cannulation during ERCP. Pancreatology. 
2014;14:S25–S26.
 45. Miao L, Li QP, Zhu MH, et al. Endoscopic transpancreatic sep-
totomy as a precutting technique for difficult bile duct cannulation. 
World J Gastroenterol. 2015;21:3978–3982.
 46. Miyatani H, Yoshida Y. Endoscopic needle knife precut papillotomy 
for inaccessible bile duct following failed pancreatic duct access. 
Clin Med Gastroenterol. 2009;2009:1–5.
 47. Wang P, Zhang W, Liu F, et al. Success and complication rates of 
two precut techniques, transpancreatic sphincterotomy and needle-
knife sphincterotomy for bile duct cannulation. J Gastrointest Surg. 
2010;14:697–704.
 48. Zhong H, Wang X, Yang L, Miao L, Ji G, Fan Z. Modified transpre-
pancreatic septotomy reduces postoperative complications after 
intractable biliary access. Medicine (Baltimore). 2018;97:e9522.
 49. Cotton P, Lehman G, Vennes J, et al. Endoscopic sphincterotomy 
complications and their management: an attempt at consensus. Gas-
trointest Endosc. 1991;37:383–393.
 50. Sterne JA, Gavaghan D, Egger M. Publication and related bias in 
meta-analysis: power of statistical tests and prevalence in the litera-
ture. J Clin Epidemiol. 2000;53):1119–1129.
 51. Rashdan A, Fogel EL, McHenry L Jr, Sherman S, Temkit M, 
Lehman GA. Improved stent characteristics for prophylaxis of post-
ERCP pancreatitis. Clin Gastroenterol Hepatol. 2004;2:322–329.
 52. Lawrence C, Cotton PB, Romagnuolo J, Payne KM, Rawls E, Hawes 
RH. Small prophylactic pancreatic duct stents: an assessment of 
spontaneous passage and stent-induced ductal abnormalities. Endos-
copy. 2007;39:1082–1085.
 53. Gódi S, Pécsi D, Hegyi P, et al. Initial experiences with transpan-
creatic sphincterotomy in Hungarian centers based on prospectively 
collected registry data. Endoscopy. 2019;51:S76.
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
